URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Ghinwa Dumyati

Concepts (136)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Cross Infection
8
2006
85
1.720
Why?
Community-Acquired Infections
7
2006
29
1.330
Why?
Clostridium difficile
4
2009
13
1.270
Why?
Enterocolitis, Pseudomembranous
3
2009
19
1.220
Why?
Staphylococcal Infections
7
2006
106
1.140
Why?
Population Surveillance
4
2007
144
1.130
Why?
Methicillin-Resistant Staphylococcus aureus
6
2009
18
1.080
Why?
Bacteremia
2
2010
39
0.960
Why?
Catheter-Related Infections
1
2011
12
0.810
Why?
Levamisole
1
2010
5
0.760
Why?
Drug Contamination
1
2010
12
0.760
Why?
Catheterization, Central Venous
1
2011
56
0.760
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2010
5
0.760
Why?
Cheek
1
2010
25
0.750
Why?
Ear, External
1
2010
25
0.750
Why?
Cocaine-Related Disorders
1
2010
22
0.740
Why?
Adjuvants, Immunologic
1
2010
118
0.700
Why?
Anti-Bacterial Agents
4
2009
442
0.470
Why?
Cervical Intraepithelial Neoplasia
1
2011
26
0.410
Why?
Papillomavirus Vaccines
1
2011
26
0.400
Why?
Precancerous Conditions
1
2011
45
0.400
Why?
Uterine Cervical Neoplasms
1
2011
125
0.390
Why?
Antiviral Agents
1
2002
170
0.370
Why?
Influenza, Human
2
1992
345
0.360
Why?
Young Adult
6
2009
1084
0.340
Why?
Antibiotic Prophylaxis
2
2008
34
0.330
Why?
Surgical Wound Infection
2
2008
59
0.330
Why?
Methicillin Resistance
2
2006
17
0.300
Why?
Microbial Sensitivity Tests
3
2009
170
0.280
Why?
Adult
9
2009
11572
0.280
Why?
Staphylococcus aureus
2
2006
109
0.280
Why?
Humans
20
1992
37165
0.270
Why?
Middle Aged
9
1992
10013
0.250
Why?
Incidence
3
2010
682
0.250
Why?
Aged
9
1992
7392
0.240
Why?
Prospective Studies
2
2011
1696
0.220
Why?
Sentinel Surveillance
1
2012
2
0.220
Why?
Proton Pump Inhibitors
1
2011
2
0.210
Why?
Virulence Factors
2
2009
75
0.210
Why?
Clostridium Infections
1
2011
6
0.210
Why?
Histamine H2 Antagonists
1
2011
13
0.200
Why?
Catheters
1
2011
6
0.200
Why?
Vancomycin Resistance
1
2011
11
0.200
Why?
Necrosis
1
2010
103
0.180
Why?
New York
2
2009
1378
0.180
Why?
Staphylococcal Vaccines
1
2009
6
0.180
Why?
Neutropenia
1
2010
70
0.180
Why?
Feces
1
2009
82
0.170
Why?
Staphylococcal Skin Infections
1
2009
7
0.170
Why?
Genotype
3
2009
473
0.170
Why?
Adolescent
6
2009
5044
0.170
Why?
Electrophoresis, Gel, Pulsed-Field
4
2006
24
0.160
Why?
United States
7
2006
2847
0.160
Why?
Sequence Analysis, DNA
1
2009
169
0.160
Why?
Quality Indicators, Health Care
1
2008
62
0.160
Why?
Hospitals
1
2008
67
0.160
Why?
Reproducibility of Results
1
2011
903
0.160
Why?
Polymerase Chain Reaction
1
2009
597
0.150
Why?
Bacterial Proteins
1
2009
377
0.140
Why?
Attitude of Health Personnel
1
2009
302
0.130
Why?
Female
7
1992
20222
0.130
Why?
Health Knowledge, Attitudes, Practice
1
2009
296
0.130
Why?
Child, Preschool
4
2009
2737
0.120
Why?
Rimantadine
1
2002
9
0.110
Why?
Zanamivir
1
2002
12
0.110
Why?
Oseltamivir
1
2002
9
0.110
Why?
Pyrans
1
2002
13
0.110
Why?
Amantadine
1
2002
21
0.110
Why?
Guanidines
1
2002
32
0.110
Why?
Acetamides
1
2002
32
0.100
Why?
Sialic Acids
1
2002
32
0.100
Why?
Drug Resistance, Viral
1
2002
65
0.100
Why?
Child
4
2009
4342
0.100
Why?
Aged, 80 and over
4
1992
2588
0.100
Why?
Infant
3
2010
2320
0.090
Why?
Papillomaviridae
1
2011
137
0.090
Why?
Influenza Vaccines
2
1992
269
0.090
Why?
Pilot Projects
1
2011
446
0.090
Why?
Infection Control
2
2009
22
0.090
Why?
DNA Fingerprinting
2
2009
9
0.090
Why?
Practice Guidelines as Topic
1
2002
319
0.080
Why?
Hospitalization
2
2011
385
0.080
Why?
Risk Factors
3
2007
2331
0.080
Why?
Adenocarcinoma
1
2011
483
0.080
Why?
Cohort Studies
2
2009
984
0.070
Why?
Retrospective Studies
2
2011
2302
0.060
Why?
Antibodies, Viral
2
1992
456
0.060
Why?
Influenza B virus
1
1994
42
0.060
Why?
Male
5
1992
20139
0.060
Why?
Treatment Outcome
2
2011
2671
0.060
Why?
Disease Outbreaks
2
1992
115
0.050
Why?
Metronidazole
1
2011
11
0.050
Why?
Fluoroquinolones
1
2011
25
0.050
Why?
Drug Interactions
1
2011
186
0.050
Why?
Health Facilities
1
2010
6
0.050
Why?
England
1
2010
46
0.050
Why?
Risk
1
2011
355
0.050
Why?
Influenza A virus
1
1992
218
0.050
Why?
Proportional Hazards Models
1
2011
426
0.050
Why?
Bacterial Typing Techniques
1
2009
24
0.040
Why?
Enterotoxins
1
2009
21
0.040
Why?
Cephalexin
1
2009
12
0.040
Why?
Outpatients
1
2009
31
0.040
Why?
Trimethoprim-Sulfamethoxazole Combination
1
2009
14
0.040
Why?
Multivariate Analysis
1
2011
548
0.040
Why?
ADP Ribose Transferases
1
2009
51
0.040
Why?
Blood
1
2009
96
0.040
Why?
Cluster Analysis
1
2009
90
0.040
Why?
Bacterial Toxins
1
2009
91
0.040
Why?
Recurrence
1
2011
697
0.040
Why?
Joints
1
2009
63
0.040
Why?
Immunization Programs
1
2009
60
0.040
Why?
Genetic Variation
1
2009
147
0.040
Why?
Cost of Illness
1
2009
79
0.040
Why?
Feedback
1
2008
76
0.040
Why?
DNA, Bacterial
1
2009
169
0.040
Why?
Cooperative Behavior
1
2008
101
0.040
Why?
Aging
1
1994
705
0.040
Why?
Logistic Models
1
2009
626
0.040
Why?
Sensitivity and Specificity
1
2009
914
0.030
Why?
Infant, Newborn
1
2011
1836
0.030
Why?
Bone and Bones
1
2009
360
0.030
Why?
Base Sequence
1
2009
1721
0.030
Why?
Molecular Sequence Data
1
2009
2046
0.030
Why?
Vaccines, Attenuated
2
1992
86
0.030
Why?
Questionnaires
1
2009
1061
0.030
Why?
Time Factors
1
2009
3234
0.030
Why?
Double-Blind Method
2
1992
996
0.020
Why?
Cold Temperature
1
1994
97
0.010
Why?
Vaccines, Inactivated
1
1992
40
0.010
Why?
Injections, Intramuscular
1
1992
70
0.010
Why?
Administration, Intranasal
1
1992
61
0.010
Why?
Homes for the Aged
1
1992
58
0.010
Why?
Vaccination
1
1994
254
0.010
Why?
Chronic Disease
1
1994
554
0.010
Why?
Nursing Homes
1
1992
192
0.010
Why?

Visualizations


Dumyati's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department